Intellia Therapeutics NTLA Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's increase (decrease) in other operating assets?
- Intellia Therapeutics (NTLA) reported increase (decrease) in other operating assets of $74K in Q1 2026.
- How has Intellia Therapeutics's increase (decrease) in other operating assets changed year-over-year?
- Intellia Therapeutics's increase (decrease) in other operating assets decreased by 99.5% year-over-year, from $13.83M to $74K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.